DK0950056T3 - N-(pyridinylamino)isoindoliner og beslægtede forbindelser - Google Patents
N-(pyridinylamino)isoindoliner og beslægtede forbindelserInfo
- Publication number
- DK0950056T3 DK0950056T3 DK97948250T DK97948250T DK0950056T3 DK 0950056 T3 DK0950056 T3 DK 0950056T3 DK 97948250 T DK97948250 T DK 97948250T DK 97948250 T DK97948250 T DK 97948250T DK 0950056 T3 DK0950056 T3 DK 0950056T3
- Authority
- DK
- Denmark
- Prior art keywords
- isoindolines
- pyridinylamino
- related compounds
- intermediates
- compositions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/76—Nitrogen atoms to which a second hetero atom is attached
- C07D213/77—Hydrazine radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/10—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- C07D263/14—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Pain & Pain Management (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US77430896A | 1996-12-27 | 1996-12-27 | |
| US08/959,789 US6004977A (en) | 1996-12-27 | 1997-10-29 | N-(pyridinylamino) isoindolines and related compounds |
| PCT/US1997/020591 WO1998029407A2 (en) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindolines for treating alzheimer's and depression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK0950056T3 true DK0950056T3 (da) | 2003-01-27 |
Family
ID=27118867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK97948250T DK0950056T3 (da) | 1996-12-27 | 1997-11-13 | N-(pyridinylamino)isoindoliner og beslægtede forbindelser |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0950056B1 (no) |
| JP (1) | JP4256937B2 (no) |
| KR (1) | KR20000062358A (no) |
| AT (1) | ATE224387T1 (no) |
| AU (1) | AU720466B2 (no) |
| BR (1) | BR9714189A (no) |
| CA (1) | CA2276203C (no) |
| DE (1) | DE69715668T2 (no) |
| DK (1) | DK0950056T3 (no) |
| ES (1) | ES2179377T3 (no) |
| HU (1) | HUP0000783A2 (no) |
| IL (1) | IL130642A0 (no) |
| NO (1) | NO993180L (no) |
| PT (1) | PT950056E (no) |
| WO (1) | WO1998029407A2 (no) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6772195B1 (en) | 1999-10-29 | 2004-08-03 | Electronic Arts, Inc. | Chat clusters for a virtual world application |
| US7229986B2 (en) * | 2000-05-16 | 2007-06-12 | Takeda Pharmaceutical Company Ltd. | Melanin-concentrating hormone antagonist |
| KR20060009686A (ko) * | 2004-07-26 | 2006-02-01 | 엘지이노텍 주식회사 | 반도체 발광소자 및 그 제조방법 |
| KR101763674B1 (ko) | 2007-01-22 | 2017-08-01 | 지티엑스, 인코포레이티드 | 핵 수용체에 결합하는 물질 |
| US9623021B2 (en) | 2007-01-22 | 2017-04-18 | Gtx, Inc. | Nuclear receptor binding agents |
| US9604931B2 (en) | 2007-01-22 | 2017-03-28 | Gtx, Inc. | Nuclear receptor binding agents |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0287982B1 (en) * | 1987-04-24 | 1994-12-07 | Hoechst-Roussel Pharmaceuticals Incorporated | N-(Pyridinyl)-1H-indol-1-amines, a process for their preparation and their use as medicaments |
| US5006537A (en) * | 1989-08-02 | 1991-04-09 | Hoechst-Roussel Pharmaceuticals, Inc. | 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones |
| NZ234726A (en) * | 1989-08-02 | 1992-01-29 | Hoechst Roussel Pharma | 2,3-dihydro-1-(pyridinylamino)-indoles and pharmaceutical compositions |
| US5102891A (en) * | 1990-07-23 | 1992-04-07 | Hoechst-Roussel Pharmaceuticals Inc. | 1-(substituted pyridinylamino)-1H-indol-5-yl substituted carbamates |
| US5177088A (en) * | 1991-04-17 | 1993-01-05 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted 3-(pyridinylamino)-indoles |
| US5328920A (en) * | 1991-04-17 | 1994-07-12 | Hoechst-Roussel Pharmaceuticals Incorporated | Substituted (pyridinylamino)-indoles |
-
1997
- 1997-11-13 AU AU54349/98A patent/AU720466B2/en not_active Ceased
- 1997-11-13 DK DK97948250T patent/DK0950056T3/da active
- 1997-11-13 HU HU0000783A patent/HUP0000783A2/hu unknown
- 1997-11-13 IL IL13064297A patent/IL130642A0/xx unknown
- 1997-11-13 KR KR1019997005846A patent/KR20000062358A/ko active IP Right Grant
- 1997-11-13 AT AT97948250T patent/ATE224387T1/de not_active IP Right Cessation
- 1997-11-13 EP EP97948250A patent/EP0950056B1/en not_active Expired - Lifetime
- 1997-11-13 ES ES97948250T patent/ES2179377T3/es not_active Expired - Lifetime
- 1997-11-13 BR BR9714189-5A patent/BR9714189A/pt not_active IP Right Cessation
- 1997-11-13 PT PT97948250T patent/PT950056E/pt unknown
- 1997-11-13 JP JP52999098A patent/JP4256937B2/ja not_active Expired - Fee Related
- 1997-11-13 WO PCT/US1997/020591 patent/WO1998029407A2/en active IP Right Grant
- 1997-11-13 DE DE69715668T patent/DE69715668T2/de not_active Expired - Fee Related
- 1997-11-13 CA CA002276203A patent/CA2276203C/en not_active Expired - Fee Related
-
1999
- 1999-06-25 NO NO993180A patent/NO993180L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| NO993180L (no) | 1999-08-26 |
| ES2179377T3 (es) | 2003-01-16 |
| IL130642A0 (en) | 2000-06-01 |
| PT950056E (pt) | 2002-12-31 |
| BR9714189A (pt) | 2000-02-29 |
| AU5434998A (en) | 1998-07-31 |
| CA2276203C (en) | 2003-07-22 |
| EP0950056A2 (en) | 1999-10-20 |
| HUP0000783A2 (hu) | 2001-04-28 |
| JP4256937B2 (ja) | 2009-04-22 |
| DE69715668D1 (de) | 2002-10-24 |
| JP2001511119A (ja) | 2001-08-07 |
| WO1998029407A3 (en) | 1998-10-22 |
| KR20000062358A (ko) | 2000-10-25 |
| WO1998029407A2 (en) | 1998-07-09 |
| DE69715668T2 (de) | 2003-07-31 |
| AU720466B2 (en) | 2000-06-01 |
| EP0950056B1 (en) | 2002-09-18 |
| NO993180D0 (no) | 1999-06-25 |
| CA2276203A1 (en) | 1998-07-09 |
| ATE224387T1 (de) | 2002-10-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO990405L (no) | Substituerte N-(indol-2-karbonyl)-glycinamider og derivater som antidiabetiske midler | |
| ATE271058T1 (de) | Mycophenol bisphosponatverbindungen | |
| TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
| DK0758904T3 (da) | Fremgangsmåder og sammensætninger til behandling af glomerulonephritis | |
| MX9700557A (es) | Dihidrobenzofuranos. | |
| TR199801255T2 (xx) | Vitronektin resept�r antagonistleri. | |
| TR200001012T2 (tr) | Yeni ariloksi-alkil-dialkilaminler. | |
| ES2194960T3 (es) | N-(2-sustituido-3-(2-aminoetil)-1h-indol-5-il)-amidas como nuevos agonistas de 5-ht1f. | |
| BG105028A (en) | Bridged indenopyrrolocarbazoles | |
| YU48698A (sh) | Karboksamidni derivati pirolidina, piperidina i heksahidroazepina za lečenje oboljenja na bazi tromboze | |
| ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
| DK0950056T3 (da) | N-(pyridinylamino)isoindoliner og beslægtede forbindelser | |
| ATE225171T1 (de) | Aminosäurederivate zur behandlung von schlaganfall | |
| IL144199A0 (en) | Novel bretylium compositions and kits, and their use in preventing and treating cardiovascular conditions | |
| DK0880569T3 (da) | Kompositioner til behandling af jord, fremgangsmåde til fremstilling deraf og anvendelse deraf | |
| GB2324091A (en) | Metalloproteinase inhibitors | |
| NO990913D0 (no) | Naftylforbindelser, intermediater, sammensetninger og metoder for anvendelse | |
| TR199901386T2 (en) | �midazopiridazinler. | |
| ATE215084T1 (de) | Imidazopyridin-azolidinone | |
| DK0671388T3 (da) | (Pyrrolidinyl)phenylcarbamater og mellemproduktforbindelser, fremgangsmåder til deres fremstilling og deres anvendelse som | |
| CA2302412A1 (en) | Aminoalkylphenol derivatives and related compounds | |
| NO975682L (no) | Pyridiniminyl-1,2-benzisoxazoler og -benzisothiazoler som anti-psykotiske midler | |
| DK0720597T3 (da) | Triarylethylenderivater til terapeutisk anvendelse | |
| DK1032580T3 (da) | Fremgangsmåde til N-desmethylering af erythromyciner og derivater deraf | |
| DK0971714T3 (da) | Metode til anvendelse af cyklooxygenase-2-inhibitorer til behandling og forebyggelse af demens |